Ethnobridging Studies

As clinical development of pharmaceuticals evolves and expands in China and Japan, it is important to bridge clinical trials data generated in the US/EU to demographic populations in Asia.

Pharmaron is uniquely positioned to assist our sponsors with global drug development strategies, including the design and execution of ethnobridging studies. We have access to Japanese and Chinese subjects and have a deep understanding and respect of important cultural nuances.

Our team can rapidly recruit and safely enroll qualified subjects from Maryland, New York, California, Pennsylvania and Washington, DC to support multi-country new drug applications. Bridging data collected at Pharmaron has supported multiple regulatory submissions in Japan and is increasingly employed with ongoing drug development in China.

Learn More: Clinical Development Services Overview